Page last updated: 2024-09-03

gefitinib and Angiitis

gefitinib has been researched along with Angiitis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hui, RC; Ko, JH; Shih, YC; Yang, CH	1
Fernández-Guarino, M; Gónzalez-López, C; Olasolo, PJ; Pérez-García, B; Ryan, AM	1

Other Studies

2 other study(ies) available for gefitinib and Angiitis

Article	Year
Necrotizing vasculitis triggered by gefitinib: an unusual clinical presentation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Mar-01, Volume: 29, Issue:7 Topics: Antineoplastic Agents; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Follow-Up Studies; Gefitinib; Humans; Immunohistochemistry; Lower Extremity; Lung Neoplasms; Male; Middle Aged; Necrosis; Neoplasm Invasiveness; Neoplasm Staging; Prednisolone; Quinazolines; Risk Assessment; Skin Diseases, Vascular; Treatment Outcome; Vasculitis	2011
Necrotizing vasculitis due to gefitinib (Iressa). International journal of dermatology, 2007, Volume: 46, Issue:8 Topics: Antineoplastic Agents; Drug Eruptions; Gefitinib; Humans; Male; Middle Aged; Quinazolines; Skin; Vasculitis	2007

Article

Year

Necrotizing vasculitis triggered by gefitinib: an unusual clinical presentation.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Mar-01, Volume: 29, Issue:7

Topics: Antineoplastic Agents; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Follow-Up Studies; Gefitinib; Humans; Immunohistochemistry; Lower Extremity; Lung Neoplasms; Male; Middle Aged; Necrosis; Neoplasm Invasiveness; Neoplasm Staging; Prednisolone; Quinazolines; Risk Assessment; Skin Diseases, Vascular; Treatment Outcome; Vasculitis

2011

Necrotizing vasculitis due to gefitinib (Iressa).

International journal of dermatology, 2007, Volume: 46, Issue:8

Topics: Antineoplastic Agents; Drug Eruptions; Gefitinib; Humans; Male; Middle Aged; Quinazolines; Skin; Vasculitis

2007